LeMaitre Vascular, Inc. LMAT
81.52
0.70
0.87%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 28.1×
Follow LMAT
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
36.92 | 31.68 | 39.55 | 33.09 |
P/S ratio |
8.23 | 7.36 | 9.71 | 8.36 | |
P/FCF ratio |
29.95 | 24.66 | 31.47 | 29.72 | |
P/Operating CF |
68.94 | 79.28 | 164.92 | 137.39 | |
P/B ratio |
5.23 | 4.67 | 6.12 | 5.22 | |
Price to Tangible BV |
7.05 | 6.23 | 8.06 | 6.77 | |
EV/Sales |
7.52 | 6.60 | 8.95 | 7.58 | |
EV/EBITDA |
24.85 | 20.81 | 27.16 | 22.42 | |
EV/Operating CF |
24.72 | 20.29 | 26.27 | 23.97 | |
EV/FCF |
27.36 | 22.14 | 29.00 | 26.95 | |
Quick Ratio |
11.28 | 10.81 | 12.08 | 13.76 | |
Current Ratio |
13.58 | 12.89 | 14.32 | 16.31 | |
Net Debt/EBITDA |
(7.55) | (8.80) | (9.62) | (8.90) | |
Debt/Assets |
28.16% | 27.39% | 26.82% | 26.40% | |
Debt/Equity |
0.44 | 0.43 | 0.42 | 0.40 | |
Asset Turnover |
0.49 | 0.43 | 0.43 | 0.43 | |
Operating CF/Net income |
1.66 | 1.49 | 0.96 | 0.94 | |
Capex/Depreciation |
(0.81) | (0.63) | (0.98) | (0.80) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.87% | 5.48% | 6.10% | 6.89% | |
Selling, General and Administrative Expense of Revenue |
37.14% | 36.96% | 39.91% | 36.26% | |
Intangible Assets out of Total Assets |
0.16 | 0.16 | 0.16 | 0.15 | |
Share Based Compensation of Revenue |
2.85% | 3.25% | 3.14% | 2.75% | |
Graham Net Nets |
0.12 | 0.13 | 0.10 | 0.12 | |
Graham Number |
29.86 | 31.64 | 33.28 | 34.64 | |
Earnings Yield |
2.71% | 3.16% | 2.53% | 3.02% | |
Free Cash Flow Yield |
3.34% | 4.05% | 3.18% | 3.36% | |
Revenue per Share |
2.69 | 2.85 | 2.92 | 3.08 | |
Operating CF per Share |
1.27 | 1.02 | 0.66 | 0.70 | |
Capex per Share |
(0.10) | (0.08) | (0.12) | (0.10) | |
Free Cash Flow per Share |
1.17 | 0.94 | 0.54 | 0.60 | |
Cash per Share |
15.14 | 15.86 | 16.11 | 16.46 | |
Shareholders Equity per Share |
16.72 | 17.38 | 17.83 | 18.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.72 | 17.38 | 17.83 | 18.39 | |
Free Cash Flow |
26.48 | 21.38 | 12.31 | 13.65 | |
Working Capital |
418.74 | 431.91 | 444.45 | 458.36 | |
Capital Expenditures |
(2.28) | (1.78) | (2.78) | (2.31) | |
Net Current Asset Value |
232.88 | 246.06 | 254.92 | 268.09 | |
EV/EBIT |
29.24 | 24.27 | 31.39 | 25.73 | |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.03 | |
Net Profit Margin |
28.44% | 24.18% | 23.56% | 24.22% | |
Price to Operating Income |
32.02 | 27.03 | 34.07 | 28.37 | |
| Other line items | |||||
Average Receivables |
32.34 | 31.84 | 35.44 | 36.11 | |
Average Payables |
2.56 | 2.70 | 3.18 | 4.08 | |
Average Inventory |
67.91 | 67.67 | 68.36 | 69.44 | |
Average Assets |
487.55 | 583.75 | 592.77 | 609.07 | |
Average Common Equity |
355.00 | 365.40 | 377.10 | 391.51 |
Columns are period end dates